Search alternatives:
marked decrease » marked increase (Expand Search)
ii mean » i mean (Expand Search), i.e mean (Expand Search)
Showing 1 - 20 results of 3,551 for search '(( ct ((((largest decrease) OR (marked decrease))) OR (larger decrease)) ) OR ( ii mean decrease ))', query time: 0.65s Refine Results
  1. 1
    Candidates from the RF method. The top 25 random forest candidates ranked by mean decrease in accuracy and mean decrease in Gini Index are in the first and second columns, respectively. The third column contains candidates common to both columns, sorted according to start position. The identifier of the peptide consists of the start to stop position within the sequence of the spike protein from ancestral SARS-CoV-II.

    Candidates from the RF method. The top 25 random forest candidates ranked by mean decrease in accuracy and mean decrease in Gini Index are in the first and second columns, respectively.... by Zoë Parker Cates (22184243)

    Published 2025
    “…The top 25 random forest candidates ranked by mean decrease in accuracy and mean decrease in Gini Index are in the first and second columns, respectively. …”
    Save to List
    Saved in:
  2. 2
    Skin marks is the S1 Fig title.

    Skin marks is the S1 Fig title. by Mercedes Soto-González (20422078)

    Published 2024
    “…</p><p>Results</p><p>The IRD decreased after both exercise programs compared to baseline measurements in AB2 (mean difference: 3.06 mm, 95% CI: 1.06 to 5.05) and in AB5 (mean difference: 2.88 mm, 95% CI: 1.59 to 4.17), confirming the long-term effect of exercise. …”
    Save to List
    Saved in:
  3. 3
    Tetrandrine decreases Mtb antigen presentation.

    Tetrandrine decreases Mtb antigen presentation. by Elham Karamooz (2584474)

    Published 2025
    Save to List
    Saved in:
  4. 4
    B2 decreases glycolytic intermediates in cells.

    B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

    Published 2025
    “…The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”
    Save to List
    Saved in:
  5. 5
    Random forest plot showing the importance of predictors (top 10) for classifying LF progression based on the Mean Decrease in Gini index.

    Random forest plot showing the importance of predictors (top 10) for classifying LF progression based on the Mean Decrease in Gini index. by Emmanuel Kobla Atsu Amewu (13946765)

    Published 2025
    Save to List
    Saved in:
  6. 6
    Change in Mean Anxiety Scores Over time by group.

    Change in Mean Anxiety Scores Over time by group. by Shaaista Budhani (21030221)

    Published 2025
    Save to List
    Saved in:
  7. 7
    Elevated concentrations of serum MMA among participants with decreased cognitive performance.

    Elevated concentrations of serum MMA among participants with decreased cognitive performance. by Yige Liu (11940344)

    Published 2025
    Save to List
    Saved in:
  8. 8
    HSF2 reversed the decrease in the MMP induced by Atr.

    HSF2 reversed the decrease in the MMP induced by Atr. by Wen Wang (6570)

    Published 2025
    Save to List
    Saved in:
  9. 9
    Decreased spindle microtubules in CAMSAP2 KO cells.

    Decreased spindle microtubules in CAMSAP2 KO cells. by Naoko Nishizawa (20536299)

    Published 2025
    Save to List
    Saved in:
  10. 10
    Boxplot comparing Ct values for HD in flies and clothes.

    Boxplot comparing Ct values for HD in flies and clothes. by Philippe Ndzomo (17706039)

    Published 2025
    Save to List
    Saved in:
  11. 11
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 12
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 13
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 14
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 15
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 16
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 17
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 18
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 19
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 20
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: